Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,209.01
(
1.02%
)
US TECH 100
26,715.60
(
0.96%
)
Dow Jones
49,652.14
(
1.62%
)
Brent Oil
110.64
(
0.26%
)
Bitcoin
77,040.01
(
0.93%
)
News Focus
News Focus
Post# of 257473
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

swampboots

Send PM Follow Ignore
Followers 179
Posts 30024
Boards Moderated 3
Alias Born 07/09/2003

swampboots

Re: None

Thursday, 10/27/2022 9:48:33 AM

Thursday, October 27, 2022 9:48:33 AM

Post# of 257473
EPIX: New method for blocking androgen receptor signaling which may be main driver of prostate cancer progression showed progress in preclinical setting, and gave stock a double yesterday.

https://www.streetinsider.com/Corporate+News/ESSA+Pharma+%28EPIX%29+Presents+Preclinical+Data+for+its+First+Generation+Androgen+Receptor+N-Terminal+Domain+Degrader/20750059.html
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today